Atea Pharmaceuticals (AVIR) Other Non-Current Liabilities (2019 - 2025)
Atea Pharmaceuticals' Other Non-Current Liabilities was $6.8 million in Q3 2025, up 9.6% from $6.2 million a year earlier and up 2.3% from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends
At the end of FY2024, Other Non-Current Liabilities at Atea Pharmaceuticals came in at $6.36 million, up 10.4% from FY2023.
- Other Non-Current Liabilities shows a five-year compound annual growth rate of 131.8% (FY2019 to FY2024).
- In earlier years, Other Non-Current Liabilities was $5.76 million in FY2023 (+9.6%), $5.26 million in FY2022 (-11.4%), $5.93 million in FY2021 and $36,000 in FY2020 (-62.1%).
- The Q3 2025 figure marks the highest quarterly Other Non-Current Liabilities in data going back to Q4 2019.
- Compared with a year earlier, Other Non-Current Liabilities has increased for nine straight quarters, with growth averaging 10.0% over the last eight quarters.
- The best year-over-year quarter for Other Non-Current Liabilities over five years was Q3 2024 (growth of 10.4%); the worst was Q4 2020 (a decline of 62.1%).
- Per Business Quant data, AVIR's Other Non-Current Liabilities in the three quarters before Q3 2025 was $6.65 million (Q2 2025), $6.5 million (Q1 2025) and $6.36 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Atea Pharmaceuticals | 417.87 Mn | 417.87 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 6.80 Mn |
| Jun 30, 2025 | 6.65 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 6.20 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Mar 31, 2024 | 5.90 Mn |
| Dec 31, 2023 | 5.76 Mn |
| Sep 30, 2023 | 5.62 Mn |
| Jun 30, 2023 | 5.49 Mn |
| Mar 31, 2023 | 5.37 Mn |
| Dec 31, 2022 | 5.26 Mn |
| Sep 30, 2022 | 5.17 Mn |
| Jun 30, 2022 | 6.01 Mn |
| Mar 31, 2022 | 5.93 Mn |
| Dec 31, 2021 | 5.93 Mn |
| Jun 30, 2021 | 29,000.00 |
| Mar 31, 2021 | 113,000.00 |
| Dec 31, 2020 | 36,000.00 |
| Sep 30, 2020 | 56,000.00 |
API Access
Atea Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();